A new clinical trial led by investigators at NewYork-Presbyterian, Columbia University Medical Center (CUMC) and Weill Cornell Medicine aims to identify and treat what may be a common underlying cause of recurrent strokes.
Researchers report encouraging preclinical results as they pursue elusive therapies that can repair scarred and poorly functioning heart tissues after cardiac injury. Scientists from the Cincinnati Children’s Heart Institute inhibited a protein that helps regulate the heart’s response to adrenaline, alleviating the disease processes in mouse models and human cardiac cells. Their data publishes Aug. 22 in the Journal of the American College of Cardiology.
Researchers at the Johns Hopkins University School of Medicine and the Mayo Clinic have compiled peer-reviewed evidence and crafted a guideline designed to help physicians and medical centers stop the use of a widely ordered blood test that adds no value in evaluating patients with suspected heart attack.
Cardiac stem cell infusions could someday help reverse the aging process in the human heart, making older ones behave younger, according to a new study from the Cedars-Sinai Heart Institute.
During the “Novel Implications for Blood Flow and Vascular Dysfunction in Non-cardiovascular Related Disease” symposium at the APS Cardiovascular Aging: New Frontiers and Old Friends conference, researchers will present findings that emphasize the interaction between age-related cardiovascular dysfunction and disease whose risk increases with age.
A new study suggests that a single exposure to e-cigarette (e-cig) vapor may be enough to impair vascular function. Researchers from West Virginia University will present findings today at the Cardiovascular Aging: New Frontiers and Old Friends meeting in Westminster, Colo.
High physical fitness is known to be related to enhanced blood vessel dilation and blood flow (endothelial function) in aging men. However, for women, endothelial function and the effect of exercise may be related more to menopausal status than fitness.
Automatic blood pressure devices are often used to assess blood pressure levels at home and in the clinic. But these devices are prone to significant errors, sometimes leading to the prescription of blood pressure-lowering medications to patients who don’t actually need them. Israeli researchers have developed a method to more accurately measure systolic blood pressure. They will present their findings at the Cardiovascular Aging: New Frontiers and Old Friends conference in Westminster, Colo.
Heart disease remains the leading cause of death in the U.S. and growing older is the greatest—and most inevitable—risk factor for it. So what, if anything, can we do to keep our hearts and arteries as healthy as possible for as long as possible? Keynote speaker Douglas Seals, PhD, of the University of Colorado Boulder, will lay the groundwork of what we know and the promising research that could combat cardiovascular aging in his presentation “Strategies for Optimal Cardiovascular Aging.” Seals will present his lecture at the Cardiovascular Aging: New Frontiers and Old Friends conference in Westminster, Colo.
• Investigators observed a step-wise increase in the risk of atrial fibrillation with decreasing kidney function. Compared with patients without kidney disease, those with severe kidney disease had a two-fold higher risk for developing atrial fibrillation. • This link held even after accounting for a range of possible contributors, including measures of cardiovascular health, and it was consistent across subgroups of participants.
Vanderbilt University Medical Center is one of nine centers across the United States to participate in the EXPAND Heart Pivotal Trial, which has the potential to change the way donor hearts are preserved and transported to recipients.
A team of researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) at Lake Nona, Fla. and Mayo Clinic in Rochester, Minn. have been awarded a three-year National Institutes of Health(NIH) grant which aims to identify molecules that could become new medicines to inhibit myocardial fibrosis. Fibrosis is a major contributor to heart failure, for which there is no known cure.
Join our virtual press briefing on August 10 at 11 am ET to hear from these organizations about new research, stories of successful programs in communities, and experts who can speak to the need to ensure all children have access to nutritious food and safe places to be physically active.
Patients without calcium buildup in the coronary arteries had significantly lower risk of future heart attack or stroke despite other high risk factors such as diabetes, high blood pressure, or bad cholesterol levels, new research from UT Southwestern cardiologists shows.
Mayo Clinic was again named the best hospital in the country in U.S. News & World Report’s annual list of top hospitals published on the U.S. News & World Report website today.
Jersey Shore University Medical Center in Neptune, Riverview Medical Center in Red Bank, Bayshore Medical Center in Holmdel and Ocean Medical Center in Brick have received the American College of Cardiology's NCDR ACTION Registry - Get with the Guidelines Platinum Achievement Award for outstanding care for cardiac patients.
A woman’s race and where on her body she packs on pounds at midlife could give her doctor valuable clues to her likelihood of having greater volumes of heart fat, a potential risk factor for heart disease, according to new research led by the University of Pittsburgh Graduate School of Public Health.
Heart failure can quickly develop or become worse during a hospital stay, even when it isn’t the primary cause for admission. Hospitals and clinicians must be diligent to identify patients at risk for secondary heart failure as they aim to improve outcomes, contain costs and prevent readmissions, according to an article in Critical Care Nurse.
A new study published in the HSS Journal by HSS anesthesiologist Michael K. Urban, MD, PhD, sheds light on reducing cardiac complications in orthopedic surgery.
A study by researchers at NewYork-Presbyterian/Columbia University Medical Center and published in JACC: Heart Failure, a journal of the American College of Cardiology Foundation, allays concerns among cardiologists that aspirin could increase the risk of hospitalization and death related to heart failure for patients with heart failure who take one of the first-line therapies: angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs).
A nationally recognized cardiothoracic surgeon and researcher, Vinod Thourani, MD, will join MedStar Heart & Vascular Institute as the chairman of Cardiac Surgery, effective August 14. Dr. Thourani brings with him extensive expertise in structural heart disease and valve surgery.
Press can register here to livestream this special session through Newswise Live on Monday, July 31 at 7:30 PM EDT
Dr. Virendra Patel has been named chief of the Division of Vascular Surgery and Endovascular Interventions and co-director of the Aortic Program at NewYork-Presbyterian/Columbia University Irving Medical Center, and an associate professor of surgery at Columbia University Medical Center (CUMC), effective July 1.
People who are diagnosed with coronary artery disease and then develop depression face a risk of death that’s twice as high as heart patients without depression, according to a major new study by researchers at Intermountain Healthcare in Salt Lake City.
Hospitals which earn the award must meet specific criteria and standards of performance for the quick and appropriate treatment of patients suffering severe heart attacks to re-establish blood flow to blocked arteries.
Scientists at The Ohio State University Wexner Medical Center have shown the human heart's sinoatrial node, the natural pacemaker, is hardwired with a backup system. This built-in redundancy maintains consistent heart rhythm, even under trying conditions.
Martin Gerdes, Ph.D., chair of the Biomedical Sciences department at New York Institute of Technology College of Osteopathic Medicine (NYITCOM), has received the prestigious Hans Peter Krayenbuehl Memorial Award from the International Academy of Cardiology for his contributions to the field of cardiac function.
The Penn Center for Precision Medicine (PCPM) Accelerator Fund awarded eight research teams from Penn Medicine in their second round of funding for the implementation of personalized medicine projects across a range of clinical specialties.
Benjamin L. Prosser, PhD, an assistant professor of Physiology, in the Perelman School of Medicine at the University of Pennsylvania, has received the Outstanding Early Career Investigator Award from the American Heart Association’s Council on Basic Cardiovascular Sciences, one of its scientific divisions
Did you know that heart disease impacts men and women differently? Research has shown that gender differences exist not only in the way disease affects the heart, but also in the symptoms and the way it is diagnosed. And, in combating this No. 1 killer of women, we must educate women on their individual risk factors and the importance of early diagnosis.
Hackensack Meridian Health hospitals honored for implementing the most timely and research-based standards outlined by the American Heart Association/American College of Cardiology Foundation's prevention guidelines.
Stem cell centers claim to offer effective treatment to patients with heart failure, despite the fact that the treatment is not approved for such use by the U.S. Food and Drug Administration (FDA), says the author of research letter in the current issue of JAMA Internal Medicine.
The Cardiovascular Research Foundation (CRF) is pleased to announce that the first issue of Structural Heart: The Journal of the Heart Team is now available online.
Using a new imaging technique that can diagnose cardiac sarcoidosis much more accurately than traditional tests, researchers from the University of Illinois at Chicago have found that the disease affects other organs in 40 percent of patients with cardiac sarcoidosis.
Regeneration specialists at UT Southwestern Medical Center will join a “dream team” of international researchers seeking ways to regenerate damaged heart muscle in heart failure patients.
Irregular heartbeat — or arrhythmia — can have sudden and often fatal consequences. A biomedical engineering team at Washington University in St. Louis examining molecular behavior in cardiac tissue recently made a surprising discovery that could someday impact treatment of the life-threatening condition.
Modest weight gains – even among those who aren’t overweight – can cause dangerous changes to the heart, but small amounts of weight loss can improve the condition, new research from UT Southwestern Medical Center cardiologists shows.
The University of Birmingham is part of a major new €19 million project aimed at breaking new ground for the development of treatments for millions of patients with heart disease in Europe.
Technology for identifying at-risk atrial fibrillation (AFib) patients was chosen as the winner of the inaugural Alexandria LaunchLabs Scholarship Award, which recognizes excellence in health care technology, entrepreneurship and business competencies.
Sudden cardiac death, and episodes of fainting and seizures from long QT syndrome are significantly lower than previously thought when patients are diagnosed and treated at a specialty center dedicated to the treatment of genetic heart rhythm diseases, according to Mayo Clinic research published in the Journal of the American College of Cardiology. This is one of the largest studies of long QT syndrome patients – people who have an inherited heart rhythm condition that can potentially cause fast and chaotic heartbeats – evaluated and treated at a single center to analyze these outcomes.
Media registration is open online for TCT 2017 (Transcatheter Cardiovascular Therapeutics), the annual Scientific Symposium of the Cardiovascular Research Foundation (CRF). TCT is the world’s premier educational meeting specializing in interventional cardiovascular medicine.
In a small proof-of-concept study, researchers at Johns Hopkins report a complex mathematical method to measure electrical communications within the heart can successfully predict the effectiveness of catheter ablation, the standard of care treatment for atrial fibrillation, the most common irregular heartbeat disorder. This has the potential to let physicians and patients know immediately following treatment whether it was effective, or whether they’ll need to anticipate another procedure in the future.
A study by researchers at the University of Birmingham has shown that GPs are prescribing anticoagulants to patients with an irregular heartbeat against official safety advice.
The first app and score to determine the one-year risk of a liver transplant patient dying or being hospitalized for a heart attack or other cardiovascular complication has been developed by Northwestern Medicine scientists.
The first app and score to determine the one-year risk of a liver transplant patient dying or being hospitalized for a heart attack or other cardiovascular complication has been developed by Northwestern Medicine scientists.
Researchers at the University of Illinois at Chicago have received a $1.2 million four-year grant from the National Institutes of Health to investigate new biological agents that mimic the effects of cooling when given during and after CPR.
University Hospitals Cleveland Medical Center and UH Harrington Heart & Vascular Institute announce the appointment of Mehdi H. Shishehbor, DO, PhD, MPH as Director of Cardiovascular Interventional Center. His areas of expertise include cardiology, vascular medicine, cardiovascular imaging, translational research and minimally invasive, catheter-based procedures such as angioplasty, stent grafts, stenting, atherectomy to treat coronary carotid artery disease, abdominal aortic aneurysms, and peripheral arterial and venous diseases.
A veteran of the U.S. Coast Guard recently received a new heart and liver at Vanderbilt University Medical Center (VUMC), one of only a handful of hospitals that have performed the dual transplant surgery this year.
Galectin-3, a protein that promotes cancer cell growth and is used as a biomarker for heart failure, has been linked to tumors observed in two rare genetic diseases, according to a study published July 11, 2017, in eLife
Inexpensive and Radiation-Free Technology Has Potential to Become a Key Screening tool for Identifying at Risk Individuals
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right